Led Avation Medical's oversubscribed $22M+ Series C, alongside Asahi Kasei, for its wearable neuromodulation technology.
Avation Medical is making neuromodulation accessible through patient-friendly wearable tech like the NEW Vivally® System, a smart wearable bladder control therapy for urinary urgency and urge urinary incontinence without the need for surgery, implants or drugs
Avation Medical is making neuromodulation accessible through patient-friendly wearable tech like the NEW Vivally® System, a smart wearable bladder control therapy for urinary urgency and urge urinary incontinence without the need for surgery, implants or drugs.